Meta Information
ID:reishi-mushroom
Name:Reishi Mushroom
Schema Version:2.4_uniform_evidence_2026_06_18
Created
2026-07-02T07:04:56Z
Model
phase-b-newfiles-claude-opus-4.8
Interactions
Target id:
/class/anticoagulants-antiplatelets
Target name:
Anticoagulants / antiplatelets
Severity:
moderate
Interaction type:
adverse
Nature:
relative
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Reishi has antiplatelet activity that can add to blood thinners and increase bleeding risk.
Actionable advice:
It is worth watching for bruising or bleeding, and this is best used cautiously with anticoagulants or antiplatelets.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Reishi (ganoderic acids) has documented antiplatelet activity; additive bleeding risk. Mechanistic.
Label source:
Class inference
Action type:
monitor
Target id:
/class/antihypertensives
Target name:
Antihypertensive drugs
Severity:
minor
Interaction type:
adverse
Nature:
relative
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Reishi may modestly lower blood pressure.
Actionable advice:
It is a good idea to check blood pressure if combining.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Mild BP-lowering activity; low-magnitude additive effect.
Label source:
Class inference
Action type:
monitor
Target id:
/class/immunosuppressants
Target name:
Immunosuppressants
Severity:
minor
Interaction type:
adverse
Nature:
relative
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Reishi is immunomodulatory and could theoretically oppose immunosuppression.
Actionable advice:
It is a good idea to talk to a specialist when on immunosuppressants.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Immunomodulatory beta-glucans; theoretical opposition to immunosuppression. Low-certainty.
Label source:
Class inference
Action type:
monitor